📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Phase I open label liver-directed gene therapy clinical trial for acute intermittent porphyria (2016)

First Author: D'Avola Delia

Attributed to: Overcoming immunological barriers to regenerative medicine funded by MRC

Abstract

No abstract provided

Bibliographic Information

Type: Journal Article/Review

Volume: 65

Parent Publication: JOURNAL OF HEPATOLOGY

Issue: 4

ISSN: 0168-8278